health Buzz

HANOI, Vietnam (AP) -- A study says more than a third of malaria-fighting drugs tested over the past decade in Southeast Asia and sub-Saharan Africa were either fake or bad quality.... - Associated Press - 0 Reads

OXFORD & NEWCASTLE, England--(BUSINESS WIRE)--e-Therapeutics plc (AIM: ETX), the drug discovery and development company, today announces its preliminary results for the year ended 31 January 2012. Highlights of 2011/12(* = events after the 31 January 2012 year end) Drug discovery renewed •   New wave of work begins using network pharmacology platform • Platform gains further intellectual property protection • Focus on cancer and neurodegenerative diseases   Clinical pipeline advancing • UK regul - BusinessWire - 0 Reads

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics presents updates on formulated mimic of miR-34 at 2012 TIDES Conference in Las Vegas and the 2012 European Microsymposium on Small RNAs in Basel, Switzerland - BusinessWire - 0 Reads

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The last study participant has been recruited to Diamyd Medical’s (STO:DIAMB)(Pink Sheets:DMYDY) Phase II study in which cancer pain is treated with the drug candidate NP2 Enkephalin. The study is thus fully enrolled and results are expected to be reported in five to seven weeks. The purpose of the Phase II study is to evaluate NP2 Enkephalin for the treatment of severe and chronic cancer pain. It is the first sizeable and placebo-controlled clinical - BusinessWire - 0 Reads

ERKHEIM, Deutschland--(BUSINESS WIRE)--Ökohaus-Pionier Baufritz erhält Gold für eigens entwickelte Bio-Dämmung HOIZ erfüllt höchste Umwelt-Kriterien & gesündeste Wohneigenschaften - BusinessWire - 0 Reads

TAMPA, Fla.--(BUSINESS WIRE)--NTRR Orders Initial Manufacturing Run of New pH Balance Formulas - BusinessWire - 0 Reads

LONDON (Reuters)- When Malaysian cyclist Azizulhasni Awang opted to postpone his Ramadan fast until after the London Games, the decision was all about going for Olympic gold. - Reuters - 0 Reads

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that John R. Plachetka, Pharm.D., the Company’s Chairman, President and Chief Executive Officer, will present at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012 at 10:30 a.m. (ET), in New York City. Dr. Plachetka’s presentation will be webcast and available for replay on POZEN’s home page at www.pozen.com. About - BusinessWire - 0 Reads

NEW YORK--(BUSINESS WIRE)--New York Genome Center (NYGC) today announced the formal commencement of their collaborative relationship with Illumina, initiated in November 2011, when Illumina was selected as the Center’s lead sequencing technology provider. As a next step in this collaboration, the Center will begin taking delivery of Illumina HiSeq 2000 and 2500 sequencing systems, creating the foundation for its pilot lab operations, which will commence in Manhattan this summer. Through this ini - BusinessWire - 0 Reads

CHICAGO--(BUSINESS WIRE)--While many young athletes consider the post-game snack to be a highlight, a new survey finds that the majority of team moms are less than excited by the lack of nutritional value in these post-game treats. The survey, conducted through a Market Tools consumer opinion panel for YoCrunch®, found that 84 percent of respondents preferred that team parents provide healthier, less-processed after-game snacks such as yogurt, sliced fruit, carrots and celery sticks over less he - BusinessWire - 0 Reads